The cell-based assays market size is expected to reach USD 28.2 Billion by 2028 and register a CAGR of 8.5% over the forecast period, according to the latest report by Reports and Data. Some key factors such as growing funding by public and private sectors and increasing utilization of cell-based assays in drug discovery are driving global market revenue growth.

Cell-based assay is a technique used for analyzing living cells based on various parameters and also aids in measuring cell toxicity, motility, proliferation in diagnostics and drug discovery. High demand for cell-based assays in drug discovery and development is rapidly escalating revenue growth. Moreover, technological developments in cell-based assays, and rising adoption of 3D-based cell assays, and increasing need for developing biologically relevant substitutes for drug discovery are some significant factors boosting market growth.

Overall high cost of assays due to high maintenance and instrument costs, lack of skilled professionals, and stringent regulations on reagent usage are some key factors expected to hamper growth of the cell-based assays market to some extent throughout the forecast period.

Top Companies Profiled in the Report Include:

Danaher Corporation (US), Thermo Fisher Scientific (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), PerkinElmer, Inc. (US), Promega Corporation (US), Charles River Laboratories (US), Lonza (Switzerland), BioAgilytix Labs (US), Reaction Biology Corporation (US), and AAT Bioquest (US).

To receive a sample copy of the global Cell-based Assays Market report, visit @ https://www.reportsanddata.com/download-summary-form/3997

Cell-based Assays Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

Major Highlights of the Cell-based Assays Market Report:

• The Cell-based Assays Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
• The report dives deeper into the market and explains the dynamic factors bolstering market growth.
• The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
• The report analyzes the Cell-based Assays Market presence across major regions of the world.
• It determines the production consumption capacities and demand supply dynamics of each regional market.
• The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
• It provides company overview and SWOT analysis of each of the market players.

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Additionally, the report consists a detailed analysis of the segmentation of the Cell-based Assays Market based on product types and end-use/application offered in the Cell-based Assays Market.

Based On Product And Service (Revenue, USD Billion, 2018 – 2028)

Consumables

Reagents

Assay Kits

Reporter Gene Assays

Cell Growth Assays

Second Messenger Assays

Cell Death Assays

Other Assay Kits

Cell Lines

Immortalized Cell Lines

Primary Cell Lines

Stem Cell Lines

Microplates

Probes Labels

Other Consumables

Instruments Software

Services

Based On Application: (Revenue, USD Billion, 2018 – 2028)

Drug Discovery

Toxicity Studies

Pharmacodynamics Studies

Pharmacokinetic Studies

Basic Research

Other Applications

Based On End Use: (Revenue, USD Billion, 2018 – 2028)

Pharmaceutical Biopharmaceutical Companies

CROs

Academic Research Institutes 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.